Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-02-26 @ 6:52 AM
Study NCT ID:
NCT03015220
Status:
COMPLETED
Last Update Posted:
2021-03-02
First Post:
2017-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization: